Skip to main content
OpenTrials
Completed

NCT Number: NCT07767669

A Controlled Study to Evaluate the Effects of a Topical Cream on Symptoms of Arthritis, Joint, and Muscle Pain

This is a randomized, triple-blind, controlled clinical trial evaluating the effects of Saje Pain Release Joint & Arthritis Cream on symptoms of arthritis, joint pain, and muscle pain in adults aged 20-65. The trial is conducted virtually over seven days, with 80 participants randomized equally into an intervention arm (active topical cream) and a control arm (matched control product).

Participants apply their assigned product three times daily to affected areas (knees, elbows, wrists, or ankles) and complete questionnaires at Baseline, 30 minutes after the first application, and at the end of Day 7. The primary objective is to assess changes in arthritis and musculoskeletal pain symptoms, while secondary objectives assess participants' perceptions of joint pain, stiffness, function, comfort, flexibility, mobility, and overall quality of life.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Arthritis Arthralgia Joint Diseases Joint Pain Joint Stiffness Muscle Pain Muscular Diseases Musculoskeletal Diseases Musculoskeletal Pain Myalgia Nervous System Diseases Neurologic Manifestations Neuromuscular Diseases Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

20 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Citruslabs

Las Vegas, Nevada, 89101, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Be male or female
  • Be aged 20-65
  • Has experienced issues regarding all of the following in the past four weeks: symptoms of arthritis of the knees, elbows, wrists, or ankles
  • joint pain and stiffness
  • Self-reported issues must be at least 3 out of 10 in severity, with 1 being the least severe and 10 being the most
  • Generally healthy - does not live with any uncontrolled chronic disease
  • If taking oral over-the-counter supplements or herbal remedies targeted at symptoms of arthritis, joint and muscle pain, has been consistently taking these for at least 3 months prior to starting the study, and is willing to maintain this routine for the study duration
  • Willing to avoid introducing any new forms of prescription medication or supplements that target symptoms of arthritis, joint and muscle pain for the study duration
  • Resides in the United States
  • Willing to maintain their current diet, sleep pattern, and activity levels for the duration of the trial

Exclusion criteria

  • Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
  • Anyone with any allergies or sensitivities to any of the study product ingredients
  • Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period)
  • Symptoms occurring in a joint that has been surgically repaired
  • Anyone unwilling to follow the study protocol
  • Anyone who identifies as having sensitive skin
  • Anyone with any history of skin cancer or any pre-cancerous lesions on their skin
  • Anyone with a history of substance abuse
  • Anyone who is currently a smoker or has been a smoker in the past 3 months
  • Currently partaking in another research study or will be partaking in any other research study at any point during this study's duration
  • Anyone with chronic skin conditions (e.g., dermatitis, eczema, psoriasis)
  • Anyone who currently takes prescription pain relief to manage their symptoms

Treatment and study plan

Intervention (Saje Pain Release Joint & Arthritis Cream)

Dietary Supplement

40 participants apply a thin layer of the Saje Pain Release Joint & Arthritis Cream to arthritis-affected areas (knees, elbows, wrists, ankles) three times daily (morning, afternoon, and evening) for seven days

Placebo Comparator

Dietary Supplement

40 participants apply a matched control product (identical in appearance and consistency to the active product but without active ingredients such as L-menthol and balsam copaiba oil) to arthritis-affected areas three times daily (morning, afternoon, and evening) for seven days

Primary outcomes

  1. Change in symptoms of arthritis

    Time frame: Baseline, 30 minutes after first application, and Day 7

    Assessed via self-reported numerical pain rating scale and the Musculoskeletal Health Questionnaire (MSK-HQ) validated questionnaire

  2. Change in symptoms of joint pain

    Time frame: Baseline, 30 minutes after first application, and Day 7

    Assessed via self-reported numerical pain rating scale and the Musculoskeletal Health Questionnaire (MSK-HQ) validated questionnaire

  3. Change in symptoms of muscle pain

    Time frame: Baseline, 30 minutes after first application, and Day 7

    Assessed via self-reported numerical pain rating scale and the Musculoskeletal Health Questionnaire (MSK-HQ) validated questionnaire

Secondary outcomes

  1. Change in self-reported joint pain

    Time frame: Baseline, 30 minutes after first application, and Day 7

    Assessed via self-reported questionnaire

  2. Change in self-reported joint stiffness

    Time frame: Baseline, 30 minutes after first application, and Day 7

    Assessed via self-reported questionnaire

  3. Change in self-reported joint function

    Time frame: Baseline, 30 minutes after first application, and Day 7

    Assessed via self-reported questionnaire

  4. Change in self-reported joint comfort

    Time frame: Baseline, 30 minutes after first application, and Day 7

    Assessed via self-reported questionnaire

  5. Change in self-reported flexibility

    Time frame: Baseline, 30 minutes after first application, and Day 7

    Assessed via self-reported questionnaire

  6. Change in self-reported mobility

    Time frame: Baseline, 30 minutes after first application, and Day 7

    Assessed via self-reported questionnaire

  7. Change in self-reported quality of life

    Time frame: Baseline, 30 minutes after first application, and Day 7

    Assessed via self-reported questionnaire

  8. Change in self-reported overall health

    Time frame: Baseline, 30 minutes after first application, and Day 7

    Assessed via self-reported questionnaire

Sponsors and collaborators

Lead sponsor

Saie Beauty

Industry

Collaborators

  • Citruslabs

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Aug 17, 2026
Registry last updated
Aug 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.